Citation Impact
Citing Papers
Ectopic Runx2 Expression in Mammary Epithelial Cells Disrupts Formation of Normal Acini Structure: Implications for Breast Cancer Progression
2009
mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1
2010
The Brazilian health system: history, advances, and challenges
2011 Standout
To Err Is Human
2000 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
dCas9 fusion to computer-designed PRC2 inhibitor reveals functional TATA box in distal promoter region
2022 StandoutNobel
Physiological Roles for mafr-1 in Reproduction and Lipid Homeostasis
2014
Osteosarcoma incidence and survival rates from 1973 to 2004
2009 Standout
The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis
2010 Standout
Formation and Function of the Myofibroblast during Tissue Repair
2007 Standout
Osteonecrosis of the Jaw in a Patient on Denosumab
2010
mTOR Signaling in Growth Control and Disease
2012 Standout
Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility
2010
Loss of the RNA polymerase III repressor MAF1 confers obesity resistance
2015
Safety at work: A meta-analytic investigation of the link between job demands, job resources, burnout, engagement, and safety outcomes.
2010 Standout
The inter-rater agreement of retrospective assessments of adverse events does not improve with two reviewers per patient record
2009
Cancer to bone: a fatal attraction
2011 Standout
Human papillomavirus oncoproteins: pathways to transformation
2010 Standout
Medication Errors and Adverse Drug Events in Pediatric Inpatients
2001 Standout
Requirement of the mTOR Kinase for the Regulation of Maf1 Phosphorylation and Control of RNA Polymerase III-dependent Transcription in Cancer Cells
2010
Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit
2006 StandoutNobel
Measuring errors and adverse events in health care
2003 Standout
Depletion of histone demethylase KDM2A inhibited cell proliferation of stem cells from apical papilla by de-repression of p15INK4B and p27Kip1
2013
Excess Length of Stay, Charges, and Mortality Attributable to Medical Injuries During Hospitalization
2003 Standout
Fundamental Cellular Processes Do Not Require Vertebrate-specific Sequences within the TATA-binding Protein
2003 StandoutNobel
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
An internal segment (residues 58–119) of the hepatitis B virus X protein is sufficient to activate MAP kinase pathways in mouse liver
2001
TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation
2009 Standout
Sch9 partially mediates TORC1 signaling to control ribosomal RNA synthesis
2009
Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
2011 Standout
The assessment of adverse events in hospitals in Brazil
2009
Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein
2015
RalGDS is required for tumor formation in a model of skin carcinogenesis
2005
PTEN: a new guardian of the genome
2008
Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study I
2004
A microRNA program in the C. elegans hypodermis couples to intestinal mTORC2/PQM-1 signaling to modulate fat transport
2016 StandoutNobel
mTOR binds to the promoters of RNA polymerase I- and III-transcribed genes
2010
Scleroderma
2009 Standout
Osteoporosis: now and the future
2011 Standout
mTOR at the nexus of nutrition, growth, ageing and disease
2020 Standout
The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada
2004 Standout
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
The incidence and nature of in-hospital adverse events: a systematic review
2008 Standout
Novel Roles for MLH3 Deficiency and TLE6-Like Amplification in DNA Mismatch Repair-Deficient Gastrointestinal Tumorigenesis and Progression
2008 StandoutNobel
Comparison of three methods for estimating rates of adverse events and rates of preventable adverse events in acute care hospitals
2004
Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice
2009
Selective Ablation of Retinoblastoma Protein Function by the RET Finger Protein
2005
Chk2 Oligomerization Studied by Phosphopeptide Ligation
2008 StandoutNobel
An Educational Intervention to Enhance Nurse Leaders' Perceptions of Patient Safety Culture
2005
Burnout and Medical Errors Among American Surgeons
2010 Standout
Hallmarks of Cellular Senescence
2018 Standout
CHK2 kinase: cancer susceptibility and cancer therapy – two sides of the same coin?
2007
The runx genes: gain or loss of function in cancer
2005
Osteosarcoma: Basic Science and Clinical Implications
2006
Cell cycle, CDKs and cancer: a changing paradigm
2009 Standout
Mature and activated osteoclasts exist in the synovium of rapidly destructive coxarthrosis
2007
Cyclins and cdks in development and cancer: a perspective
2005
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis
2004 Standout
Ras, PI(3)K and mTOR signalling controls tumour cell growth
2006 StandoutNature
Complex Oncogenic Signaling Networks Regulate Brain Tumor‐Initiating Cells and Their Progenies: Pivotal Roles of Wild‐Type EGFR, EGFRvIII Mutant and Hedgehog Cascades and Novel Multitargeted Therapies
2011
ROS and the DNA damage response in cancer
2018 Standout
Why nature really chose phosphate
2013 StandoutNobel
Networks and hubs for the transcriptional control of osteoblastogenesis
2006
Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed
2010 Standout
Cytotoxic copper(ii) salicylaldehyde semicarbazone complexes: Mode of action and proteomic analysis
2010
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Signal Pathways Which Promote Invasion and Metastasis: Critical and Distinct Contributions of Extracellular Signal-Regulated Kinase and Ral-Specific Guanine Exchange Factor Pathways
2001
Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase
2018 StandoutNobel
Peptidic degron in EID1 is recognized by an SCF E3 ligase complex containing the orphan F-box protein FBXO21
2015 StandoutNobel
Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study I
2004
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Natural Polyphenols for Prevention and Treatment of Cancer
2016 Standout
MAB-10/NAB acts with LIN-29/EGR to regulate terminal differentiation and the transition from larva to adult in C. elegans
2011 Nobel
Translating Gene Expression Into Clinical Care: Sarcomas As a Paradigm
2010
Hypoxia-Inducible Factor 1 Is Activated by Dysregulated Cyclin E during Mammary Epithelial Morphogenesis
2011
Microfluidics in the selection of affinity reagents for the detection of cancer: paving a way towards future diagnostics
2016
Spermidine in health and disease
2018 StandoutScience
Transforming Growth Factor-β1 to the Bone
2005
Five System Barriers to Achieving Ultrasafe Health Care
2005 Standout
Increased Expression of Integrin αvβ3 Contributes to the Establishment of Autocrine TGF-β Signaling in Scleroderma Fibroblasts
2005
Impact and preventability of adverse events in Spanish public hospitals: results of the Spanish National Study of Adverse Events (ENEAS)
2009
Heterozygous Disruption of the TATA-Binding Protein Gene in DT40 Cells Causes Reduced cdc25B Phosphatase Expression and Delayed Mitosis
2001
Mechanisms of Oncogene-Induced Replication Stress: Jigsaw Falling into Place
2018
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Regulation of cell proliferation by hypoxia-inducible factors
2015 StandoutNobel
Ribosome Biogenesis: Emerging Evidence for a Central Role in the Regulation of Skeletal Muscle Mass
2014 Standout
Emerging Droplet Microfluidics
2017 Standout
Adverse events in New Zealand public hospitals I: occurrence and impact.
2002
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
2014 Standout
The Measurement of Observer Agreement for Categorical Data
1977 Standout
Works of Sandra Johnson being referenced
Epidermal Growth Factor Receptor 1 (EGFR1) and Its Variant EGFRvIII Regulate TATA-Binding Protein Expression through Distinct Pathways
2008
Enhanced RNA Polymerase III-dependent Transcription Is Required for Oncogenic Transformation*
2008
A role for αV integrin subunit in TGF-β-stimulated osteoclastogenesis
2003
Molecular Profiling of Giant Cell Tumor of Bone and the Osteoclastic Localization of Ligand for Receptor Activator of Nuclear Factor κB
2005
Maf1 Is a Novel Target of PTEN and PI3K Signaling That Negatively Regulates Oncogenesis and Lipid Metabolism
2014
RNA Metabolism and Oncogenesis
2008 Science
Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma
2004
PTEN Represses RNA Polymerase III-Dependent Transcription by Targeting the TFIIIB Complex
2008
Adverse events regional feasibility study: methodological results.
2001
Transcriptional Regulation of the TATA-Binding Protein by Ras Cellular Signaling
2000
Genetic and Epigenetic Analysis of CHEK2 in Sporadic Breast, Colon, and Ovarian Cancers
2006
Increased Expression of TATA-Binding Protein, the Central Transcription Factor, Can Contribute to Oncogenesis
2003
Adverse events regional feasibility study: indicative findings.
2001
Notes from the Field:Cluster of Lymphogranuloma Venereum Cases Among Men Who Have Sex with Men — Michigan, August 2015–April 2016
2016